Low-dose naloxone does not improve morphine-induced nausea, vomiting, or pruritus.
Publication Type | Academic Article |
Authors | Greenwald P, Provataris J, Coffey J, Bijur P, Gallagher E |
Journal | Am J Emerg Med |
Volume | 23 |
Issue | 1 |
Pagination | 35-9 |
Date Published | 01/01/2005 |
ISSN | 0735-6757 |
Keywords | Morphine, Naloxone, Narcotic Antagonists, Nausea, Pruritus, Vomiting |
Abstract | OBJECTIVE: We tested the hypothesis that low-dose naloxone delivered with intravenous (IV) bolus morphine to emergency department patients in pain would reduce nausea. METHODS: Randomized, double-blind, placebo-controlled trial. Patients receiving 0.10 mg/kg morphine IV bolus rated pain, nausea, and pruritus on 100-mm visual analog scales at enrollment and 20 minutes. Patients were randomized to 0.25 microg/kg naloxone or equal volume placebo administered with IV morphine. RESULTS: One hundred thirty-one enrolled, 99 (76%) treated according to protocol with sufficient data for analysis. At 20 minutes the difference between groups (naloxone-placebo) was 1 mm (95% CI [confidence interval], -9 to 11) for nausea, 1 mm (95% CI, -3 to 3) for pruritus, 4% (95% CI, -1 to 9) for vomiting, and 0% (95% CI, -5 to 5) for rescue antiemetics. Pain was significantly reduced in both groups. CONCLUSION: Addition of 0.25 microg/kg naloxone to bolus morphine does not improve nausea, pruritus, vomiting, or reduce use of rescue antiemetics when administered to emergency department patients in pain. |
DOI | 10.1016/j.ajem.2004.01.001 |
PubMed ID | 15672335 |